miR-18a-5p	NN
Inhibits	VBZ
Sub-pleural	JJ
Pulmonary	JJ
Fibrosis	NN
by	IN
Targeting	NN
TGF-b	NN
Receptor	NN
II	CD
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
progressive	JJ
lung	NN
disease	NN
that	WDT
typically	RB
leads	VBZ
to	TO
respiratory	JJ
failure	NN
and	CC
death	NN
within	IN
3-5	CD
years	NNS
of	IN
diagnosis	NN
.	.

Sub-pleural	JJ
pulmonary	JJ
fibrosis	NN
is	VBZ
a	DT
pathological	JJ
hallmark	NN
of	IN
IPF	NN
.	.

Bleomycin	NN
treatment	NN
of	IN
mice	NNS
is	VBZ
a	DT
an	DT
established	VBN
pulmonary	JJ
fibrosis	NN
model	NN
.	.

We	PRP
recently	RB
showed	VBD
that	IN
bleomycin-induced	JJ
epithelial-mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
contributes	VBZ
to	TO
pleural	JJ
mesothelial	JJ
cell	NN
(	(
PMC	NN
)	)
migration	NN
and	CC
sub-pleural	JJ
pulmonary	JJ
fibrosis	NN
.	.

MicroRNA	NN
(	(
miRNA	NN
)	)
expression	NN
has	VBZ
recently	RB
been	VBN
implicated	VBN
in	IN
the	DT
pathogenesis	NN
of	IN
IPF	NN
.	.

However	RB
,	,
changes	NNS
in	IN
miRNA	NN
expression	NN
in	IN
PMCs	NNS
and	CC
sub-pleural	JJ
fibrosis	NN
have	VBP
not	RB
been	VBN
reported	VBN
.	.

Using	VBG
cultured	VBN
PMCs	NNS
and	CC
a	DT
pulmonary	JJ
fibrosis	NN
animal	NN
model	NN
,	,
we	PRP
found	VBD
that	IN
miR-18a-5p	NN
was	VBD
reduced	VBN
in	IN
PMCs	NNS
treated	VBN
with	IN
bleomycin	NN
and	CC
that	IN
downregulation	NN
of	IN
miR-18a-5p	NN
contributed	VBD
to	TO
EMT	NN
of	IN
PMCs	NNS
.	.

Furthermore	RB
,	,
we	PRP
determined	VBD
that	IN
miR-18a-5p	NN
binds	VBZ
to	TO
the	DT
3	CD
'	''
UTR	NN
region	NN
of	IN
transforming-growth-factor-b	JJ
receptor	NN
II	CD
(	(
TGF-bRII	NN
)	)
mRNA	NN
,	,
and	CC
this	DT
is	VBZ
associated	VBN
with	IN
reduced	VBN
TGF-bRII	NN
expression	NN
and	CC
suppression	NN
of	IN
TGF-b-Smad2	NN
/	:
3	CD
signaling	NN
.	.

Overexpression	NN
of	IN
miR-18a-5p	NN
prevented	VBD
bleomycin-induced	JJ
EMT	NN
of	IN
PMC	NN
and	CC
inhibited	VBD
bleomycin-induced	JJ
sub-pleural	JJ
fibrosis	NN
in	IN
mice	NNS
.	.

Taken	VBN
together	RB
,	,
our	PRP$
data	NNS
indicate	VBP
that	IN
downregulated	JJ
miR-18a-5p	NN
mediates	VBZ
sub-pleural	JJ
pulmonary	JJ
fibrosis	NN
through	IN
upregulation	NN
of	IN
its	PRP$
target	NN
,	,
TGF-bRII	NN
,	,
and	CC
that	IN
overexpression	NN
of	IN
miR-18a-5p	NN
might	MD
therefore	RB
provide	VB
a	DT
novel	JJ
approach	NN
to	TO
the	DT
treatment	NN
of	IN
IPF	NN
.	.

